References:
1. Wang, FS; Zhang, C; What to do next to control the 2019-nCoV epidemic?[J].Lancet.2020,395(10222):391-393
2. Wang, D; Hu, B; Hu, C; et al.Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.[J].JAMA.2020,():
3. Kim JY, Choe PG, Oh Y,etal.The First Case of 2019 Novel Coronavirus Pneumonia Imported into Korea from Wuhan, China: Implication for Infection Prevention and Control Measures.J Korean Med Sci. 2020 Feb 10;35(5):e61. doi: 10.3346/jkms.2020.35.e61.
4. 2019-nCoV National Incident Room Surveillance Team.2019 nCoV acute respiratory disease, Australia Epidemiology Report 1 (Reporting week 26 January - 1 February 2020).Commun Dis Intell (2018). 2020 Feb 6;44. doi: 10.33321/cdi.2019.44.13.
5. Michelle L Holshue , Chas DeBolt , Scott Lindquist, et al. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med 2020. PMID 32004427
6.Marta Giovanetti , Domenico Benvenuto , Silvia Angeletti , The First Two Cases of 2019-nCoV in Italy: Where They Come From? J Med Virol 2020. PMID 32022275
7. Lu, CW; Liu, XF; Jia, ZF; 2019-nCoV transmission through the ocular surface must not be ignored.[J].Lancet.2020,():
8. Wenhua Liang, Weijie Guan, Ruchong Chen, et al. Tumor patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol,2020.Feb14,DOI:https://doi.org/10.1016/S1470-2045(20)30096-6.